NSEShareholders meeting2h ago · 5 Sept 2026, 06:38 pm
Shareholders meeting
Lincoln Pharmaceuticals Limited · LINCOLN
✦ AI SummaryResults
Lincoln Pharmaceuticals Limited has informed the Exchange regarding Notice of 32nd Annual General Meeting to be held on September 30, 2026, to consider and adopt audited financial statements, declare dividend, and re-appoint directors.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Lincoln Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026.
Attachments (1)
📄pdf
Download →
LINCOLN_05092026183745_Notice2526.pdf
View document text
LINCOLN
PHARMACEUTICALS LTD.
HEALTHCAREFORALL
Date: September 05, 2026
To To
The Manager, The Manager,
Listing Department, The Department of Corporate Service,
National Stock Exchange of India BSE Limited, (BSE)
Limited, (NSE) 25th Floor, Phiroze Jeejeebhoy Tower,
Exchange Plaza, C-1, Block-G, Bandra-Kurla Dalal Street, Fort, Mumbai – 400 001.
Complex, Bandra (E), Mumbai – 400 051.
Scrip Code – LINCOLN Scrip Code – 531633
Dear Sir / Madam,
Sub: Notice of 32nd Annual General Meeting of the Company.
This is to inform that the 32nd Annual General Meeting ("AGM") of the members of the Company will
be held on Wednesday, September 30, 2026 at 11:00 a.m. (IST) through Video Conferencing ("VC") /
Other Audio-Visual Means ("OAVM"), in accordance with the relevant circulars issued by the Ministry of
Corporate Affairs and the Securities and Exchange Board of India, we hereby enclose the Notice of 32nd
Annual General Meeting of the Company which is being sent to the members through electronic mode.
The same is also uploaded on the website of the Company at www.lincolnpharma.com.
We request you to kindly take the above information on your record.
Thanking you,
Yours faithfully,
For Lincoln Pharmaceuticals Limited
Trusha Shah
Company Secretary &
Compliance Officer
Encl: a/a
Regd. Office: "Lincoln House", Science City Road, Sola, Ahmedabad-380 060. Gujarat, India ����
Phone: +91-79-4107 8000 I Fax: +91-79-4107 8062 I CIN L24230GJ1995PLC024288
E-mail: info@lincolnpharma.com I Website : www.lincolnpharma.com
Factory: 10, 12, 13, Trimul Estate, Near Khatraj Chokadi, P.O. Khatraj-382721. lntertek 014
Ta.: Kalol, Dist. Gandhinagar, [Guj.] I Phone: +91-79-49135000 I E-mail: khatraj@lincolnpharma.com
LINCOLN
PHARMACEUTICALS LTD.
HEAL TH CARE FOR ALL
NOTICE
NOTICE is hereby given that the 32nd (Thirty Second) Annual General Meeting (“AGM”) of the members of Lincoln
Pharmaceuticals Limited (“the Company” or “LPL”) will be held on Wednesday, September 30, 2026 at 11:00 a.m. (IST)
through Video Conference (“VC”) or Other Audio-Visual Means (“OAVM”) to transact the following businesses. The
venue of the AGM shall be deemed to be the registered office of the Company i.e. at “LINCOLN HOUSE”, Behind Satyam
Complex, Science City Road, Sola, Ahmedabad-380060.
ORDINARY BUSINESSES:
1. To receive, consider and adopt the audited Standalone and Consolidated financial statements of the Company for
the financial year ended March 31, 2026, the reports of Board of Directors and Auditors thereon; and if thought fit, to
pass with or without modification(s), the following resolution as an Ordinary Resolution:
RESOLVED THAT the Standalone and Consolidated Audited Financial Statements of the Company for the financial
year ended March 31, 2026, the reports of Board of Directors and the Auditors thereon, be and are hereby received,
considered and adopted.”
2. To declare dividend of 1.80/- (i.e.18%) per equity share of . 10/- each for the financial year 2025-2026.
3. To appoint a director in place of Mr. Hashmukh I. Patel [DIN: 00104834], who retires by rotation and being
eligible offers himself for re-appointment as a Director:
To consider and, if thought fit, to pass the following Resolution as an Ordinary Resolution:
RESOLVED THAT Mr. Hashmukh I. Patel [DIN: 00104834], Whole Time Director of the Company, who retires by
rotation at 32nd Annual General Meeting of the Company and being eligible for re-appointment, be and is hereby
re-appointed as Director of the Company, who shall be liable to retire by rotation.”
4. To appoint a director in place of Mr. Munjal Mahendrabhai Patel [DIN: 02319308], who retires by rotation and
being eligible offers himself for re-appointment as a director:
To consider and, if thought fit, to pass the following Resolution as an Ordinary Resolution:
RESOLVED THAT Mr. Munjal Mahendrabhai Patel [DIN: 02319308], Whole Time Director of the Company, who shall
be liable to retire by rotation at 32nd Annual General Meeting of the Company and being eligible for re-appointment,
be and is hereby re-appointed as a Director of the Company.”
SPECIAL BUSINESS:
5. To consider and if thought fit, to pass with or without modification(s), the following resolution as an ORDINARY
RESOLUTION: -
R ESOLVED THAT pursuant to provisions of section 148 (3) and other applicable provisions, if any, of the Companies
Act, 2013 read with the Companies (Audit and Auditors) Rules, 2014 and the Companies (Cost Records and Audit)
Rules, 2014,(including any statutory modification(s)or re-enactment(s) thereof for the time being in force), the
consent of the members be and is hereby accorded to ratify the payment of remuneration of ₹ 2,50,000/- (Rupees
Two Lakh Fifty Thousand Only) p.a. plus goods and service tax and out of pocket expense at actual to Kiran J. Mehta
& Co., Cost Accountants (FRN: 000025), Ahmedabad who were appointed by the board of directors as cost auditors
to conduct the audit of cost records maintained by the Company pertaining to products manufactured by the
Company for the financial year ended on March 31, 2027.
By Order of the Board
For Lincoln Pharmaceuticals Limited
Trusha K. Shah
Place: Ahmedabad Company Secretary
Date: August 13, 2026 Membership No. A59416
Registered Office:
“LINCOLN HOUSE”, Behind Satyam Complex,
Science City Road, Sola, Ahmedabad,
Gujarat – 380 060, India.
56 Annual Report 2025-26
CORPORATE STATUTORY FINANCIAL
OVERVIEW REPORT STATEMENTS
NOTES:
1. Ministry of Corporate Affairs in India (MCA) vide its General Circular No. 03/2025 dated 22nd September, 2025,
extended the relaxation to the companies to conduct their AGM through video conferencing (VC) or other audio-
visual means (OAVM) dispensing personal presence of the members at the meeting provided that such companies
shall follow the procedures as prescribed in MCA General Circular No. 20/2020 dated 5th May, 2020 (‘MCA Circulars’).
To continuously encouraging wider participation of the shareholders at the AGM, Company is pleased to provide
facility to attend and participate in the AGM through VC/OAVM. Thus, Members can attend and participate in the
meeting through VC/OAVM from their respective locations following the instructions given herein.
2. As AGM is being held pursuant to the MCA and SEBI Circulars through VC / OAVM, the facility to appoint proxy
will not be required for the AGM and hence the proxy form and attendance slip are not annexed to this Notice.
Also, the route map is not annexed to this Notice. However, in pursuance of Section 112 and Section 113 of the Act,
representatives of the Members such as the President of India or the Governor of a State or Body Corporates is
entitled to appoint authorised representative to attend the AGM through VC / OAVM and participate thereat and
cast their votes through e-voting.
3. The explanatory statement pursuant to Section 102 of the Act, in respect of special businesses is annexed herewith
and forms integral part of the Notice.
4. Members attending the AGM through VC/OAVM shall be counted for the purpose of reckoning the quorum under
Section 103 of the Companies Act, 2013.
5. Institutional / corporate shareholders (i.e. other than individual / HUF, NRI etc.) are required to send a scanned copy of
board resolution / authorization letter for authorizing the representative to attend the AGM of the Company through
VC / OAVM on its behalf and to cast their vote through remote e-voting. The said board resolution / authorization
letter shall be sent to Parikh Dave & Associates, the Scrutinizer, appointed by the Board, by email on their registered
email address to evoting@parikhdave.com.
6. In compliance with the MCA and SEBI Circulars, notice of the 32nd AGM along with the Annual Report 2025-2026 is
being sent through electronic mode only to those Members whose E-Mail address is registered with the Company’s
Registrar and Share Transfer Agent (“RTA”) / Depository Participants (“DPs”) as on Friday, August 28, 2026. Members
may note that the Notice of AGM and the
[Showing first 8,000 characters — download PDF for full document]